肝炎糖尿病治疗的进展:一篇综述
Yanru Deng1, Keyu Li2, Ang Li2
1Department of Clinical Nutrition, West China Hospital; Sichuan University, Chengdu, Sichuan Province, China.
Medicine
|November 21, 2023
概括
肝致糖尿病 (HD) 是慢性肝病的并发症,预后不佳,缺乏明确的治疗方法. 本综述探讨了最近的进展,以找到有效的疾病疾病管理策略.
科学领域:
- 内分泌学和新陈代谢学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝炎性糖尿病 (HD) 是一种与慢性肝病,特别是肝硬化相关的代谢障碍.
- 患有HD的患者面临严重的并发症,如胃肠道出血和肝脏脑病.
- 疾病进展往往反映肝硬化进展,增加死亡率和肝癌风险.
研究的目的:
- 审查最近在治疗肝病性糖尿病方面的进展.
- 为了确定潜在的有效的治疗策略,为HD.
- 改善HD患者的临床管理和预后.
主要方法:
- 系统性文献综述最近关于疾病治疗的研究.
- 对专注于肝病并发症新型治疗方法的研究进行分析.
- 综合发现,以确定有希望的治疗途径.
主要成果:
- 目前的文献显示,缺乏确立的,系统的HD治疗方案.
- 新兴的研究探讨了各种治疗目标和干预措施来管理HD.
- 最近的进展显示出潜力,但需要进一步的临床验证.
结论:
- 迫切需要肝炎糖尿病的有效治疗策略.
- 进一步的研究和临床试验对于开发一种系统的HD管理方法至关重要.
- 改善HD治疗可以显著改善患者的治疗结果并降低死亡率.
相关概念视频
Diabetes: Management and Pharmacotherapy
289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Oral Hypoglycemic Agents: Biguanides and Glitazones
210
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
210
Pathophysiology of Diabetes
950
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
950


